Thursday, 3 October 2019 | 9.00-11.30 | Kursaal C
The recent EU initiatives on vaccination reveal the unique complexity of the vaccine ecosystem. Decisions on, but not limited to, prioritisation of new pathogens for research and development (R&D), regulatory requirements, manufacturing and supply capacity, industrial and technology policies, procurement, pricing policies, forecasting and stockpiling practices, and financing of vaccination programmes, all impact access to vaccines globally and in a given country. Ultimately, the result should lead to a predictable and sustainable supply of innovative, qualitative and affordable vaccines to meet public health needs.
This session will aim to help the audience understand and recognise the many different components of a vaccine ecosystem, and how they are all interconnected. It will feature a panel debate followed by an interactive simulation exercise, providing the forum for participants not only to listen to experts, but actively take part and understand their respective roles as well.
PANOS KANAVOS, Associate Professor of International Health Policy, Department of Health Policy, London School of Economics and Political Science & Deputy Director, LSE Health
RUTE HORTA, Executive Director of Drug Information Centre (CEDIME) at Portuguese National Association of Pharmacies (ANF)
ALEXANDER KORT, SVP Corporate Development, Themis Bioscience GmbH
ANTONIO GAUDIOSO, Secretary General, Active Citizenship Network
ADRIAN PANA, Health Policy Analyst, Founder & CEO Center for Health Outcomes and Evaluation; former Secretary of State, Ministry of Health, Romania
WOLFGANG PHILIPP, Head of Unit, DG Health and Food Safety, European Commission
NATASHA AZZOPARDI-MUSCAT, Consultant, Public Health Medicine, Directorate for Health Information & Research, Malta, & President, European Public Health Association (EUPHA)
The simulation exercise will be run by JORIS SPROKHOLT, Academic Researcher in Immunology and Infectious Diseases, Transmissible BV.